Different effect of hypercholesterolemia on mortality in hemodialysis patients based on coronary artery disease or myocardial infarction

Yen-Chung Lin, Yi Chun Lin, Hsi-Hsien Chen, Tzen-Wen Chen, Chih Cheng Hsu, Chiung-Chi Peng, Mai-Szu Wu

研究成果: 雜誌貢獻文章

5 引文 (Scopus)

摘要

Background: Studies on the association of total cholesterol (TC) levels and mortality in hemodialysis (HD) patients demonstrated conflicting results. The differenct effect of Hypercholesterolemia on HD patients based on the presence of myocardial infarction (MI) or coronary artery disease (CAD) is unknown. Methods: We analyzed data from the Taiwan Renal Registry Data System (TWRDS) between 2005 and 2012. Patients were divided into MI/CAD or non-MI/CAD group. The primary outcome was three-year mortality. The association between primary outcome and first year average TC and effect of change in cholesterol level between the first and third year of dialysis were explored. Results: Of 90,795 HD patients, 77,762 (85.6%) patients were assigned to non-MI/CAD group and 13,033 (14.4%) to the MI/CAD group. In the non-MI/CAD subjects, both TC > 250 mg/dL and < 150 mg/dL were associated with increased risk of mortality (adjusted hazard ratio [HR]; 95% confidence interval [CI]: 1.27; 1.17-1.37 and 1.14; 1.11-1.18) compared to the reference (TC: 150-200 mg/dL). In the MI/CAD patients, only TC < 150 mg/dL had increased risk (HR; 95% CI: 1.15; 1.08-1.24). In addition, patients of the non-MI/CAD group with highest level of TC (>250 mg/dL) in both first and third year of dialysis had a 64% increased risk for mortality (HR: 1.64, 95% CI: 1.51-1.80). Conclusion: In this nationwide hemodialysis cohort, hypercholesterolemia was associated with increased mortality in HD patients without MI/CAD. Further investigation on primary prevention of CAD with statin is warranted.
原文英語
文章編號211
期刊Lipids in Health and Disease
15
發行號1
DOIs
出版狀態已發佈 - 十二月 8 2016

指紋

Hypercholesterolemia
Renal Dialysis
Coronary Artery Disease
Myocardial Infarction
Mortality
Cholesterol
Infarction
Dialysis
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Primary Prevention
Taiwan
Information Systems
Registries
Kidney

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

引用此文

@article{34abdc5866bd42bd902821ee4a4a568c,
title = "Different effect of hypercholesterolemia on mortality in hemodialysis patients based on coronary artery disease or myocardial infarction",
abstract = "Background: Studies on the association of total cholesterol (TC) levels and mortality in hemodialysis (HD) patients demonstrated conflicting results. The differenct effect of Hypercholesterolemia on HD patients based on the presence of myocardial infarction (MI) or coronary artery disease (CAD) is unknown. Methods: We analyzed data from the Taiwan Renal Registry Data System (TWRDS) between 2005 and 2012. Patients were divided into MI/CAD or non-MI/CAD group. The primary outcome was three-year mortality. The association between primary outcome and first year average TC and effect of change in cholesterol level between the first and third year of dialysis were explored. Results: Of 90,795 HD patients, 77,762 (85.6{\%}) patients were assigned to non-MI/CAD group and 13,033 (14.4{\%}) to the MI/CAD group. In the non-MI/CAD subjects, both TC > 250 mg/dL and < 150 mg/dL were associated with increased risk of mortality (adjusted hazard ratio [HR]; 95{\%} confidence interval [CI]: 1.27; 1.17-1.37 and 1.14; 1.11-1.18) compared to the reference (TC: 150-200 mg/dL). In the MI/CAD patients, only TC < 150 mg/dL had increased risk (HR; 95{\%} CI: 1.15; 1.08-1.24). In addition, patients of the non-MI/CAD group with highest level of TC (>250 mg/dL) in both first and third year of dialysis had a 64{\%} increased risk for mortality (HR: 1.64, 95{\%} CI: 1.51-1.80). Conclusion: In this nationwide hemodialysis cohort, hypercholesterolemia was associated with increased mortality in HD patients without MI/CAD. Further investigation on primary prevention of CAD with statin is warranted.",
keywords = "Coronary artery disease, Hemodialysis, Mortality, Myocardial infarction, Total cholesterol",
author = "Yen-Chung Lin and Lin, {Yi Chun} and Hsi-Hsien Chen and Tzen-Wen Chen and Hsu, {Chih Cheng} and Chiung-Chi Peng and Mai-Szu Wu",
year = "2016",
month = "12",
day = "8",
doi = "10.1186/s12944-016-0380-7",
language = "English",
volume = "15",
journal = "Lipids in Health and Disease",
issn = "1476-511X",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Different effect of hypercholesterolemia on mortality in hemodialysis patients based on coronary artery disease or myocardial infarction

AU - Lin, Yen-Chung

AU - Lin, Yi Chun

AU - Chen, Hsi-Hsien

AU - Chen, Tzen-Wen

AU - Hsu, Chih Cheng

AU - Peng, Chiung-Chi

AU - Wu, Mai-Szu

PY - 2016/12/8

Y1 - 2016/12/8

N2 - Background: Studies on the association of total cholesterol (TC) levels and mortality in hemodialysis (HD) patients demonstrated conflicting results. The differenct effect of Hypercholesterolemia on HD patients based on the presence of myocardial infarction (MI) or coronary artery disease (CAD) is unknown. Methods: We analyzed data from the Taiwan Renal Registry Data System (TWRDS) between 2005 and 2012. Patients were divided into MI/CAD or non-MI/CAD group. The primary outcome was three-year mortality. The association between primary outcome and first year average TC and effect of change in cholesterol level between the first and third year of dialysis were explored. Results: Of 90,795 HD patients, 77,762 (85.6%) patients were assigned to non-MI/CAD group and 13,033 (14.4%) to the MI/CAD group. In the non-MI/CAD subjects, both TC > 250 mg/dL and < 150 mg/dL were associated with increased risk of mortality (adjusted hazard ratio [HR]; 95% confidence interval [CI]: 1.27; 1.17-1.37 and 1.14; 1.11-1.18) compared to the reference (TC: 150-200 mg/dL). In the MI/CAD patients, only TC < 150 mg/dL had increased risk (HR; 95% CI: 1.15; 1.08-1.24). In addition, patients of the non-MI/CAD group with highest level of TC (>250 mg/dL) in both first and third year of dialysis had a 64% increased risk for mortality (HR: 1.64, 95% CI: 1.51-1.80). Conclusion: In this nationwide hemodialysis cohort, hypercholesterolemia was associated with increased mortality in HD patients without MI/CAD. Further investigation on primary prevention of CAD with statin is warranted.

AB - Background: Studies on the association of total cholesterol (TC) levels and mortality in hemodialysis (HD) patients demonstrated conflicting results. The differenct effect of Hypercholesterolemia on HD patients based on the presence of myocardial infarction (MI) or coronary artery disease (CAD) is unknown. Methods: We analyzed data from the Taiwan Renal Registry Data System (TWRDS) between 2005 and 2012. Patients were divided into MI/CAD or non-MI/CAD group. The primary outcome was three-year mortality. The association between primary outcome and first year average TC and effect of change in cholesterol level between the first and third year of dialysis were explored. Results: Of 90,795 HD patients, 77,762 (85.6%) patients were assigned to non-MI/CAD group and 13,033 (14.4%) to the MI/CAD group. In the non-MI/CAD subjects, both TC > 250 mg/dL and < 150 mg/dL were associated with increased risk of mortality (adjusted hazard ratio [HR]; 95% confidence interval [CI]: 1.27; 1.17-1.37 and 1.14; 1.11-1.18) compared to the reference (TC: 150-200 mg/dL). In the MI/CAD patients, only TC < 150 mg/dL had increased risk (HR; 95% CI: 1.15; 1.08-1.24). In addition, patients of the non-MI/CAD group with highest level of TC (>250 mg/dL) in both first and third year of dialysis had a 64% increased risk for mortality (HR: 1.64, 95% CI: 1.51-1.80). Conclusion: In this nationwide hemodialysis cohort, hypercholesterolemia was associated with increased mortality in HD patients without MI/CAD. Further investigation on primary prevention of CAD with statin is warranted.

KW - Coronary artery disease

KW - Hemodialysis

KW - Mortality

KW - Myocardial infarction

KW - Total cholesterol

UR - http://www.scopus.com/inward/record.url?scp=85002373939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002373939&partnerID=8YFLogxK

U2 - 10.1186/s12944-016-0380-7

DO - 10.1186/s12944-016-0380-7

M3 - Article

C2 - 27927204

AN - SCOPUS:85002373939

VL - 15

JO - Lipids in Health and Disease

JF - Lipids in Health and Disease

SN - 1476-511X

IS - 1

M1 - 211

ER -